The majority (~ 85%) of JMML cases has a driver mutation in one of the genes of the canonical RAS pathway, most frequently in PTPN11, NRAS, KRAS, NF1, or CBL [26, 29, 30]. This evidence concerns the gene NF1 and juvenile myelomonocytic leukemia.